Clincosm LogoSign in Get a demo

adenocarcinoma of the pancreas

Showing 26 - 50 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Boston (Bevacizumab, Erlotinib, Gemcitabine)

Completed
Has Results
  • Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • Boston, Massachusetts
  • +2 more
Apr 7, 2017

Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer Trial in Worldwide (AMG 479, Placebo, gemcitabine)

Terminated
  • Adenocarcinoma of the Pancreas
  • +15 more
  • AMG 479
  • +2 more
  • Fullerton, California
  • +164 more
Oct 26, 2016

Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in United States (Placebo, AMG 479, AMG

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Placebo
  • +2 more
  • Alhambra, California
  • +43 more
Oct 26, 2016

Pancreas Cancer, Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Camden (Gemcitabine, Stereotactic Radiosurgery)

Unknown status
  • Pancreas Cancer
  • +4 more
  • Camden, New Jersey
    MD Anderson Cancer Center at Cooper
Mar 8, 2016

Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Indianapolis (Gemcitabine, Sorafenib, Radiotherapy)

Completed
  • Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • Gemcitabine, Sorafenib
  • Radiotherapy
  • Indianapolis, Indiana
    Indiana University Simon Cancer Center
Feb 26, 2016

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Beverly Hills, California
  • +25 more
Jul 20, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Cleveland (dasatinib,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Cleveland, Ohio
    Case Western Reserve University
Apr 14, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage I Pancreatic Cancer Trial (bevacizumab, gemcitabine HCl,

Withdrawn
  • Adenocarcinoma of the Pancreas
  • +4 more
  • (no location specified)
Apr 27, 2015

Solid Tumour, Adenocarcinoma of the Colorectal, Adenocarcinoma of the Pancreas Trial (CEP-37250/KHK2804)

Completed
  • Solid Tumour
  • +2 more
  • (no location specified)
Mar 17, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Aurora, Denver, Baltimore

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • Aurora, Colorado
  • +2 more
Nov 19, 2014

Adenocarcinoma of the Pancreas, Locally Advanced, Unresectable Trial in Worldwide (Gemcitabine, AMG 479, Placebo)

Terminated
  • Adenocarcinoma of the Pancreas
  • +2 more
  • San Francisco, California
  • +34 more
Aug 6, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (gemcitabine HCl,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 23, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Memphis, Nashville (drug,

Terminated
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Memphis, Tennessee
  • +1 more
Jun 23, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in New York (alvocidib, docetaxel)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
May 12, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (cetuximab, gemcitabine

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +4 more
  • cetuximab
  • +3 more
  • Chicago, Illinois
    University of Chicago
Apr 28, 2014

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Cleveland (sunitinib malate,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • sunitinib malate
  • gemcitabine hydrochloride
  • Cleveland, Ohio
    Case Western Reserve University
Feb 21, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Hamilton, Toronto

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +3 more
  • Hamilton, Ontario, Canada
  • +1 more
Feb 21, 2014

Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in United States (drug, other,

Terminated
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +4 more
  • Beverly Hills, California
  • +5 more
Sep 27, 2013

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Rochester (radiation therapy,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • radiation therapy
  • +3 more
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Jul 15, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (sorafenib tosylate,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • gemcitabine hydrochloride
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 1, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (drug, biological,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gemcitabine hydrochloride
  • +5 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Adenocarcinoma of the Pancreas, Normal Pancreatic Exocrine Function Trial in Rotterdam (Timing of start treatment with

Withdrawn
  • Adenocarcinoma of the Pancreas
  • Normal Pancreatic Exocrine Function
  • Timing of start treatment with pancreatic enzymes
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Feb 21, 2013